Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics.

about

Novel insights into chromosomal conformations in cancer.Targeting bromodomain and extraterminal proteins in breast cancer.

P2860

Q47098649-2924451F-7562-4248-ABF6-311872EFC9A9 Q47385983-20D8EF25-724C-4222-90B7-DFFF0F229268

P2860

Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics.

Item

http://www.wikidata.org/entity/Q44988870

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@en

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@nl

type

Item

label

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@en

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@nl

prefLabel

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@en

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@nl

P1476

Potent Dual BET Bromodomain-Ki ...... robes and Cancer Therapeutics.

@en

P2093

Conor C Lynch

http://www.w3.org/2001/XMLSchema#string

Cyril H Benes

http://www.w3.org/2001/XMLSchema#string

Ernst Schönbrunn

http://www.w3.org/2001/XMLSchema#string

Gary W Reuther

http://www.w3.org/2001/XMLSchema#string

Harshani R Lawrence

http://www.w3.org/2001/XMLSchema#string

Jin-Yi Zhu

http://www.w3.org/2001/XMLSchema#string

Marilena Tauro

http://www.w3.org/2001/XMLSchema#string

Muhammad Ayaz

http://www.w3.org/2001/XMLSchema#string

Nicholas J Lawrence

http://www.w3.org/2001/XMLSchema#string

Norbert Berndt

http://www.w3.org/2001/XMLSchema#string

P2860

The mechanism of release of P-TEFb and HEXIM1 from the 7SK snRNP by viral and cellular activators includes a conformational change in 7SK

Selective inhibition of BET bromodomains

Janus kinases in immune cell signaling

A census of human cancer genes

PHENIX: a comprehensive Python-based system for macromolecular structure solution

Durability of Kinase-Directed Therapies--A Network Perspective on Response and Resistance

Cyclin-Dependent Kinase Inhibitor Dinaciclib Interacts with the Acetyl-Lysine Recognition Site of Bromodomains

Acetyl-lysine Binding Site of Bromodomain-Containing Protein 4 (BRD4) Interacts with Diverse Kinase Inhibitors

Dual kinase-bromodomain inhibitors for rationally designed polypharmacology

ROS1 rearrangements define a unique molecular class of lung cancers.

P304

1054-1067

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1535-7163.MCT-16-0568-T

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28336808

http://www.w3.org/2001/XMLSchema#string

P932

5457702

http://www.w3.org/2001/XMLSchema#string

Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics.

about

P2860

P2860

Potent Dual BET Bromodomain-Kinase Inhibitors as Value-Added Multitargeted Chemical Probes and Cancer Therapeutics.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P932